Keywords
Thrombotic microangiopathy, thrombotic thrombocytopenic purpura, prasugrel
Abstract
We report a case of a 64-year-old male who, 44 days after starting treatment with prasugrel, presented with severe thrombocytopenia, anemia, renal failure, and severe ADAMTS13 activity deficiency, along with a high titer of autoantibodies to this protease.
References
Views: 1532
HTML downloads: 513
PDF downloads: 643
Figures downloads: 0
Published:
2016-07-27
Issue:
Vol. 3 No. 5
(view)